November 22 -- Sino Biopharmaceutical (1177.HK) acquired a 52 percent stake in Shaoyang Bone Hospital for 57.20 million yuan, reports aastocks.com, citing a company filing.

Sino Biopharma will inject another 7.8 million yuan into the hospital.

Sino Biopharma said the investment will allow the company to participate in the reform of public hospitals.

The acquisition will complement and help to further develop its own business, added the company.